Program / AmoyDx
AmoyDx molecular diagnostics for precision medicine in oncology
Amoy Diagnostics Co., Ltd. — AmoyDx — focuses on molecular diagnostics for precision medicine in oncology. As the representative for Serbia and Montenegro, Sineks Medical connects healthcare institutions with AmoyDx solutions for mutation detection, gene expression and the companion diagnostics approach.
About the program
AmoyDx develops tests for personalized oncology therapy
The company has a portfolio of molecular diagnostic tests focused on mutation detection and gene expression measurement in tumor tissue.
AmoyDx is a company focused on molecular diagnostics in precision medicine, especially in oncology. Its tests are used for biomarker analysis that may be important for therapy selection, indication monitoring and clinical decision-making.
The previous Sineks content highlights ADx-ARMS and Super-ARMS technologies, as well as a test portfolio that includes EGFR, RAS, ALK, BRAF, PIK3CA, ROS1 and other markers. The tests are intended for laboratories, healthcare institutions, academic institutions and pharmaceutical companies.
- Molecular diagnostics for precision medicine in oncology.
- Tests for mutation detection and gene expression measurement.
- The portfolio includes biomarkers such as EGFR, RAS, ALK, BRAF, PIK3CA and ROS1.
- Sineks Medical represents AmoyDx for Serbia and Montenegro.
Fields of application
Where do AmoyDx tests most often fit?
AmoyDx solutions are relevant for institutions and laboratories working with oncology samples, biomarkers and a personalized therapeutic approach.
Precision oncology
For clinical processes in which the therapeutic decision is connected with the molecular profile of the tumor and relevant biomarkers.
Molecular laboratories
For laboratories working with PCR, mutation analysis, FFPE sample processing and validated IVD tests.
Oncology institutions
For institutions that want to connect diagnostics, therapy selection and multidisciplinary decision-making in oncology.
Companion diagnostics
The AmoyDx portfolio can be connected with therapeutic indications and partnerships with pharmaceutical companies.
Academic institutions
For research and academic teams working with molecular markers and oncology samples.
Pharmaceutical companies
For cooperation in the development, validation and support of diagnostic solutions within personalized medicine.
Biomarkers and tests
Portfolio for key oncology markers
The AmoyDx portfolio includes multiple tests for mutations and genetic changes that are important in modern oncology diagnostics.
EGFR
Tests for biomarkers often considered in the context of lung cancer and targeted therapy.
KRAS / NRAS
Tests for detecting KRAS and NRAS mutations relevant for molecular diagnostics and therapeutic decision-making according to applicable protocols.
ALK / ROS1
Tests connected with precision oncology and the companion diagnostics approach.
BRAF / PIK3CA
Markers that may be part of a molecular profile and a wider diagnostic algorithm.
RET
Part of a wider portfolio of tests and panels for molecular oncology diagnostics.
FFPE samples
Previous content mentions tests focused on mutation detection and gene expression in FFPE tumor tissue.
Real-time PCR
The tests are based on proprietary real-time PCR technology called ADx-ARMS.
IVD application
Some tests have CE marking for diagnostic use in Europe, according to the previous content.
Technology
ADx-ARMS and Super-ARMS as the foundation of the AmoyDx approach
Previous Sineks content specifically highlights AmoyDx proprietary technologies for real-time PCR diagnostics and high testing sensitivity.
ADx-ARMS
Proprietary real-time PCR technology used in AmoyDx tests for mutation detection.
Super-ARMS
A technology platform connected with a more advanced approach to mutation detection in oncology samples.
Sensitivity and accuracy
Previous content states 1% sensitivity and 99% accuracy for AmoyDx tests, in the context of their validated systems.
Results in about 90 minutes
The tests are described as easy to perform, with results within about 90 minutes on common PCR instruments.
Related solutions
AmoyDx in radiotherapy and oncology diagnostics
We connect AmoyDx with the segment of molecular diagnostics, precision oncology and oncology diagnostics for specialist institutions and laboratories.
AmoyDx
Molecular diagnostics for precision medicine, oncology and biomarker testing.
Radiotherapy and oncology diagnostics
An overview of complex technologies that Sineks Medical connects with specialist institutions.
Stargen / Accuray
A related segment of advanced oncology, radiotherapy and high-precision medical systems.
ZapX
An advanced solution for stereotactic radiosurgery in specialized institutions.
Process and users
Who are AmoyDx solutions intended for?
For AmoyDx, we do not display a generic customer portfolio. It is more important to show user types and the discussion process around laboratory needs.
Molecular laboratories
Laboratories working with real-time PCR, oncology biomarkers, FFPE samples and IVD diagnostics.
Send inquiryOncology centers
Institutions that connect diagnostics, multidisciplinary decision-making and a personalized therapeutic approach.
Radiotherapy and oncology diagnosticsAcademic institutions
Research and academic teams working with molecular markers and oncology samples.
ContactNeeds assessment
The first step is a description of the laboratory, tests of interest, existing PCR instruments and indications.
Request consultationFAQ
Frequently asked questions about AmoyDx solutions
Answers for laboratories, healthcare institutions and teams considering AmoyDx molecular diagnostics.
AmoyDx is a company focused on molecular diagnostics for precision medicine in oncology, including tests for mutations, gene expression and biomarkers relevant for therapeutic decision-making.
Previous Sineks content lists EGFR, RAS, ALK, BRAF, PIK3CA, ROS1, RET and related panels for molecular oncology diagnostics.
They are intended for molecular laboratories, healthcare institutions, oncology centers, academic institutions and pharmaceutical companies, in accordance with indications and laboratory conditions.
Send a description of the laboratory, types of tests you are interested in, existing PCR equipment and clinical indications. Based on that, Sineks Medical can help choose the appropriate solution.
